These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3064175)

  • 1. Pharmacology of putative neurotransmitters and receptors: 5-hydroxytryptamine.
    Roberts MH
    Prog Brain Res; 1988; 77():329-38. PubMed ID: 3064175
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-HT1A receptors and 5-HT1A-mediated responses: effect of treatments that modify serotonergic neurotransmission.
    Frazer A; Hensler JG
    Ann N Y Acad Sci; 1990; 600():460-74; discussion 474-5. PubMed ID: 2174665
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiated 5-hydroxytryptophan response suppression following 5,7-dihydroxytryptamine raphe lesions in an animal model of depression.
    Engleman EA; Hingtgen JN; Zhou FC; Murphy JM; Aprison MH
    Biol Psychiatry; 1991 Aug; 30(3):317-20. PubMed ID: 1717002
    [No Abstract]   [Full Text] [Related]  

  • 4. Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Bolaños FJ; Schechter LE; Laporte AM; Hamon M; Gozlan H
    Proc West Pharmacol Soc; 1991; 34():387-93. PubMed ID: 1838607
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of cocaine with central serotonergic neuronal systems: cellular electrophysiologic approaches.
    Lakoski JM; Cunningham KA
    NIDA Res Monogr; 1988; 88():78-91. PubMed ID: 3145459
    [No Abstract]   [Full Text] [Related]  

  • 7. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
    Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
    Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sleep in the rate following raphe lesion: pharmacology of the serotonin system].
    Adrien J; Laguzzi R; Bourgoin S; Hamon M
    Waking Sleeping; 1980; 4(2):119-29. PubMed ID: 6447408
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain.
    Rueter LE; Blier P
    Br J Pharmacol; 1999 Feb; 126(3):627-38. PubMed ID: 10188973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin, serotonin receptors, serotonin receptor subtype agonists and pain.
    Pascual J
    Pain; 1990 Jan; 40(1):115-116. PubMed ID: 2339009
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
    Piñeyro G; de Montigny C; Blier P
    Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP mediates circadian phase shifts induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus.
    Duncan MJ; Davis VA
    Brain Res; 2005 Oct; 1058(1-2):10-6. PubMed ID: 16150426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET.
    Tauscher J; Verhoeff NP; Christensen BK; Hussey D; Meyer JH; Kecojevic A; Javanmard M; Kasper S; Kapur S
    Neuropsychopharmacology; 2001 May; 24(5):522-30. PubMed ID: 11282252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.
    Koe BK
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():13-7. PubMed ID: 2175308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential activation of the 5-HT1(A) serotonin receptor and TrkB induces the serotonergic neuronal phenotype.
    Galter D; Unsicker K
    Mol Cell Neurosci; 2000 May; 15(5):446-55. PubMed ID: 10833301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why clinical pharmacology of serotonin?
    Sicuteri F; Schönbaum E
    Monogr Neural Sci; 1976; 3():1-7. PubMed ID: 790165
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of 5-HT(2) serotonergic receptors of the nucleus raphe magnus and nucleus reticularis gigantocellularis/paragigantocellularis complex neural networks in the antinociceptive phenomenon that follows the post-ictal immobility syndrome.
    de Oliveira RC; de Oliveira R; Ferreira CM; Coimbra NC
    Exp Neurol; 2006 Sep; 201(1):144-53. PubMed ID: 16842781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; de Montigny C; Blier P
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1239-47. PubMed ID: 9732384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.